Search results for query: *

https://www.relmada.com/product-development REL-1017 is in Phase 3 trials now. It is focusing on brain hyperexcitability. We all know that's a major factor in tinnitus. This drug doesn't belong in the Research News forum since it has no focus on tinnitus, but for those with reactive tinnitus...